Fast Five Quiz: Treatment in Relapsed Multiple Sclerosis

Kerstin Hellwig, MD; Christopher Luzzio, MD


November 22, 2022

Multiple sclerosis (MS) is an immune-mediated inflammatory disease that attacks myelinated axons in the central nervous system and often causes significant physical disability over time. The hallmark of MS is symptomatic episodes separated in time and space, heralded by symptoms of central nervous system involvement. These attacks or exacerbations last longer than 24 hours, with relapses occurring months or years apart and affecting different anatomic locations. Numerous clinical situations have been associated with increased or decreased risk for relapse.

Of the four disease courses identified in MS, the most common is relapsing-remitting MS (RRMS), characterized by a cycle of relapse and remission. In the initial stages, RRMS has a largely inflammatory pathology that, over time, becomes primarily neurodegenerative. Most cases of RRMS ultimately evolve to secondary progressive MS (SPMS) after about 15 years, though disease course is variable. There is no cure for MS; however, in recent years, a widening array of novel and increasingly effective therapies have become available.

How familiar are you with the latest developments in the treatment of RRMS? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.